Background: The multifactorial nature of rosacea and chronic spontaneous urticaria (CSU) pathogenesis complicates the achievement of satisfactory treatment outcomes. 13C urea breath test (UBT) has been identified as an accurate, non-invasive, and quick procedure to detect the presence of Helicobacter pylori (H. pylori) with high sensitivity and specificity. Objective: In this study, we aim to assess the correlation between H. pylori infection and rosacea and CSU patients. Methods: A cross-sectional, observational study was conducted on patients with rosacea and CSU in the dermatology clinic at King Khalid University Hospital in Riyadh, Saudi Arabia. History and physical examination were performed by a dermatologist. H. pylori 13C-UBT detection was performed in all subjects. Results: In total, 114 patients were included in this current study, with 41 rosacea and 73 urticaria patients. The vast majority of our subjects were females (96.5%). The mean (±SD) age was 42.3 (±12.7). More than half (58.8%) of the examined samples were positive for 13C-UBT; however, positive results were significantly higher in the rosacea patients (73.2%) compared to the urticaria group (50.7%), with a p-value of 0.019. Conclusion: Our findings underline the significant association of H. pylori with rosacea and CSU regardless of the presence or absence of gastrointestinal symptoms. We thus recommend the inclusion of H. pylori testing in the routine workup of CSU and rosacea patients.
Topical Corticosteroids (TCS) are the most commonly prescribed medications in Dermatology practice. They are considered safe and effective if used at the appropriate location and for the appropriate duration. Local side effects due to TCS are not uncommon. However, systemic side effects are rare. Herein, we present a patient who developed adrenal insufficiency secondary to the use of TCS.
1 January 2022 in Journal of Nature and Science of Medicine
Background: The application of skin-whitening products to have fairer and lighter skin tone has now become common practice worldwide. Research supports that even skin distribution and fairer skin are the symbol of attractiveness and superiority. Objective: This study aims to determine the belief and awareness about the composition and hazardous effects of skin-whitening products among Saudi population. Design: This was a descriptive cross-sectional study. Methods: A total of 395 respondents participated in the study. This was a cross-sectional survey study that was carried out in Riyadh, Saudi Arabia. The two-part questionnaire was filled by a convenience sample of 395 Saudi participants. The survey questions were related to whitening creams effectiveness, reasons of use, and the safety of the whitening products. The survey data were analyzed using SPSS version 21. Results: The most representative age group who responded was 18–25 years (26%), 73% were female (n = 185), and 53.1% were married. Regarding the level of knowledge among respondents on skin-whitening cream-negative implications, it was found that there is an association between age and whitening cream side effects (<0.05). Ages between 18 and 25 (73.5% said yes) and between 31 and 35 (75.6%) suffer higher from side effects of whitening creams as compared to the other age groups. Conclusion: The analysis shows that cosmetic use of skin-whitening creams is more common among females. The people of all age groups were not aware of the deleterious effects of skin-whitening creams. From the study, it was found that people who suffer from the negative effects of creams were mostly of age less than 35.
Cutaneous leishmaniasis incidence has been rising in the past couple of decades. Standard therapy often includes antileishmanial drugs; however, due to their low safety and toxicity threshold, alternative treatments are being investigated. The association between COVID-19 and cutaneous leishmaniasis remains unclear and exploring this connection may offer crucial insights into the pathophysiology of and treatment strategies for infected patients. In this article, we describe a case of a male patient with a history of cardiac and other comorbidities who presented with cutaneous leishmaniasis in the form of impetigo-like skin lesions after being infected with COVID-19. Due to the patient’s poor cardiac profile, sodium stibogluconate was not used and an alternative therapeutic approach was employed. The patient was treated with oral terbinafine, cryotherapy on specific lesions, and a course of cephalexin. Following the course of treatment and subsequent follow-up, the patient exhibited complete resolution and healing of the lesions with scarring, and no active lesions or recurrence were observed. This case highlights the potential for alternative treatment strategies for cutaneous leishmaniasis in patients with comorbidities and emphasizes the importance of further research to better understand the link between COVID-19 and cutaneous leishmaniasis.